The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival results of phase I dose escalation of stereotactic body radiation therapy and concurrent cisplatin for re-irradiation of unresectable, recurrent head and neck squamous cell carcinoma.
 
Michelle Echevarria
No Relationships to Disclose
 
Christine H. Chung
Consulting or Advisory Role - Bristol-Myers Squibb; CUE Biopharma; Mirati Therapeutics; Sanofi/Regeneron
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Brooklyn ImmunoTherapeutics (Inst); Ignyta (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Mirati Therapeutics
 
Kedar Kirtane
Stock and Other Ownership Interests - Agenus; Immunomedics; Macrogenics; Myovant Sciences; Oncternal Therapeutics; Seagen; Veru
 
Jameel Muzaffar
No Relationships to Disclose
 
Julie Ann Kish
No Relationships to Disclose
 
John Arrington
No Relationships to Disclose
 
Joaquim Farinhas
Stock and Other Ownership Interests - Kannact
 
Jimmy J. Caudell
Honoraria - Varian Medical Systems
Consulting or Advisory Role - Varian Medical Systems
Research Funding - Varian Medical Systems